BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15780905)

  • 1. Overview of monoclonal antibodies in cancer therapy: present and promise.
    Stern M; Herrmann R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer antibodies.
    Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
    Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-based therapeutics in oncology.
    Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal and bispecific antibodies as novel therapeutics.
    Booy EP; Johar D; Maddika S; Pirzada H; Sahib MM; Gehrke I; Loewen S; Louis SF; Kadkhoda K; Mowat M; Los M
    Arch Immunol Ther Exp (Warsz); 2006; 54(2):85-101. PubMed ID: 16648969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer monoclonal antibodies for hematological malignancies.
    Castillo J; Winer E; Quesenberry P
    Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
    Ricart AD; Tolcher AW
    Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
    Sheikh N
    Curr Opin Mol Ther; 2003 Aug; 5(4):428-32. PubMed ID: 14513687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody therapy for solid tumors.
    Green MC; Murray JL; Hortobagyi GN
    Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibritumomab: new drug. Interesting concept, disappointing in practice.
    Prescrire Int; 2005 Oct; 14(79):171-3. PubMed ID: 16285071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in the treatment of cancer, Part 2.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(16):1631-41; quiz 1642-3. PubMed ID: 12966906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New agents and future directions in biotherapy.
    Sorokin P
    Clin J Oncol Nurs; 2002; 6(1):19-24. PubMed ID: 11842484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
    Frederick PJ; Straughn JM; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2009 Jun; 113(3):384-90. PubMed ID: 19232697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies in clinical hematology and oncology.
    Nagorsen D; Thiel E
    Curr Opin Investig Drugs; 2007 Dec; 8(12):996-1001. PubMed ID: 18058570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of prostate cancer.
    Smith-Jones PM
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody therapy for prostate cancer.
    Jakobovits A
    Handb Exp Pharmacol; 2008; (181):237-56. PubMed ID: 18071949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB-directed immunotherapy: antibodies in current practice and promising new agents.
    Friedländer E; Barok M; Szöllosi J; Vereb G
    Immunol Lett; 2008 Mar; 116(2):126-40. PubMed ID: 18201769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.
    Mirick GR; Bradt BM; Denardo SJ; Denardo GL
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):251-7. PubMed ID: 15640788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):323-9. PubMed ID: 12113055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.